Multiple Myeloma, version 3.2018: Featured updates to the NCCN guidelines

Shaji K. Kumar; Natalie S. Callander; Melissa Alsina; Djordje Atanackovic; J. Sybil Biermann; Jorge Castillo; Jason C. Chandler; Caitlin Costello; Matthew Faiman; Henry C. Fung; Kelly Godby; Craig Hofmeister; Leona Holmberg; Sarah Holstein; Carol Ann Huff; Yubin Kang; Adetola Kassim; Michaela Liedtke; Ehsan Malek; Thomas Martin; Vishala T. Neppalli; James Omel; Noopur Raje; Seema Singhal; George Somlo; Keith Stockerl-Goldstein; Donna Weber; Joachim Yahalom; Rashmi Kumar; Dorothy A. Shead

doi:10.6004/jnccn.2018.0002

Multiple Myeloma, version 3.2018: Featured updates to the NCCN guidelines

Shaji K. Kumar, Natalie S. Callander, Melissa Alsina, Djordje Atanackovic, J. Sybil Biermann, Jorge Castillo, Jason C. Chandler, Caitlin Costello, Matthew Faiman, Henry C. Fung, Kelly Godby, Craig Hofmeister, Leona Holmberg, Sarah Holstein, Carol Ann Huff, Yubin Kang, Adetola Kassim, Michaela Liedtke, Ehsan Malek, Thomas MartinVishala T. Neppalli, James Omel, Noopur Raje, Seema Singhal, George Somlo, Keith Stockerl-Goldstein, Donna Weber, Joachim Yahalom, Rashmi Kumar, Dorothy A. Shead

Research output: Contribution to journal › Review article › peer-review

93 Scopus citations

Abstract

The NCCN Guidelines for Multiple Myeloma provide recommendations for diagnosis, evaluation, treatment, including supportive-care, and follow-up for patients with myeloma. These NCCN Guidelines Insights highlight the important updates/changes specific to the myeloma therapy options in the 2018 version of the NCCN Guidelines.

Original language	English
Pages (from-to)	11-20
Number of pages	10
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	16
Issue number	1
DOIs	https://doi.org/10.6004/jnccn.2018.0002
State	Published - Jan 1 2018

Access to Document

10.6004/jnccn.2018.0002

Cite this

Kumar, S. K., Callander, N. S., Alsina, M., Atanackovic, D., Biermann, J. S., Castillo, J., Chandler, J. C., Costello, C., Faiman, M., Fung, H. C., Godby, K., Hofmeister, C., Holmberg, L., Holstein, S., Huff, C. A., Kang, Y., Kassim, A., Liedtke, M., Malek, E., ... Shead, D. A. (2018). Multiple Myeloma, version 3.2018: Featured updates to the NCCN guidelines. JNCCN Journal of the National Comprehensive Cancer Network, 16(1), 11-20. https://doi.org/10.6004/jnccn.2018.0002

@article{afb8836e3f36442aa9e721f86c458cb7,

title = "Multiple Myeloma, version 3.2018: Featured updates to the NCCN guidelines",

abstract = "The NCCN Guidelines for Multiple Myeloma provide recommendations for diagnosis, evaluation, treatment, including supportive-care, and follow-up for patients with myeloma. These NCCN Guidelines Insights highlight the important updates/changes specific to the myeloma therapy options in the 2018 version of the NCCN Guidelines.",

author = "Kumar, {Shaji K.} and Callander, {Natalie S.} and Melissa Alsina and Djordje Atanackovic and Biermann, {J. Sybil} and Jorge Castillo and Chandler, {Jason C.} and Caitlin Costello and Matthew Faiman and Fung, {Henry C.} and Kelly Godby and Craig Hofmeister and Leona Holmberg and Sarah Holstein and Huff, {Carol Ann} and Yubin Kang and Adetola Kassim and Michaela Liedtke and Ehsan Malek and Thomas Martin and Neppalli, {Vishala T.} and James Omel and Noopur Raje and Seema Singhal and George Somlo and Keith Stockerl-Goldstein and Donna Weber and Joachim Yahalom and Rashmi Kumar and Shead, {Dorothy A.}",

note = "Funding Information: This activity is supported by educational grants from AstraZeneca, Celldex Therapeutics, Celgene Corporation, Genentech, Jazz Pharmaceuticals, Inc., Novartis Pharmaceuticals Corporation, and Seattle Genetics, Inc. This activity is supported by independent educational grants from AbbVie, Merck & Co., Inc. and NOVOCURE. Publisher Copyright: {\textcopyright} 2018 JNCCN-Journal of the National Comprehensive Cancer Network.",

year = "2018",

month = jan,

day = "1",

doi = "10.6004/jnccn.2018.0002",

language = "English",

volume = "16",

pages = "11--20",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

number = "1",

}

Kumar, SK, Callander, NS, Alsina, M, Atanackovic, D, Biermann, JS, Castillo, J, Chandler, JC, Costello, C, Faiman, M, Fung, HC, Godby, K, Hofmeister, C, Holmberg, L, Holstein, S, Huff, CA, Kang, Y, Kassim, A, Liedtke, M, Malek, E, Martin, T, Neppalli, VT, Omel, J, Raje, N, Singhal, S, Somlo, G, Stockerl-Goldstein, K, Weber, D, Yahalom, J, Kumar, R & Shead, DA 2018, 'Multiple Myeloma, version 3.2018: Featured updates to the NCCN guidelines', JNCCN Journal of the National Comprehensive Cancer Network, vol. 16, no. 1, pp. 11-20. https://doi.org/10.6004/jnccn.2018.0002

TY - JOUR

T1 - Multiple Myeloma, version 3.2018

T2 - Featured updates to the NCCN guidelines

AU - Kumar, Shaji K.

AU - Callander, Natalie S.

AU - Alsina, Melissa

AU - Atanackovic, Djordje

AU - Biermann, J. Sybil

AU - Castillo, Jorge

AU - Chandler, Jason C.

AU - Costello, Caitlin

AU - Faiman, Matthew

AU - Fung, Henry C.

AU - Godby, Kelly

AU - Hofmeister, Craig

AU - Holmberg, Leona

AU - Holstein, Sarah

AU - Huff, Carol Ann

AU - Kang, Yubin

AU - Kassim, Adetola

AU - Liedtke, Michaela

AU - Malek, Ehsan

AU - Martin, Thomas

AU - Neppalli, Vishala T.

AU - Omel, James

AU - Raje, Noopur

AU - Singhal, Seema

AU - Somlo, George

AU - Stockerl-Goldstein, Keith

AU - Weber, Donna

AU - Yahalom, Joachim

AU - Kumar, Rashmi

AU - Shead, Dorothy A.

N1 - Funding Information: This activity is supported by educational grants from AstraZeneca, Celldex Therapeutics, Celgene Corporation, Genentech, Jazz Pharmaceuticals, Inc., Novartis Pharmaceuticals Corporation, and Seattle Genetics, Inc. This activity is supported by independent educational grants from AbbVie, Merck & Co., Inc. and NOVOCURE. Publisher Copyright: © 2018 JNCCN-Journal of the National Comprehensive Cancer Network.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - The NCCN Guidelines for Multiple Myeloma provide recommendations for diagnosis, evaluation, treatment, including supportive-care, and follow-up for patients with myeloma. These NCCN Guidelines Insights highlight the important updates/changes specific to the myeloma therapy options in the 2018 version of the NCCN Guidelines.

AB - The NCCN Guidelines for Multiple Myeloma provide recommendations for diagnosis, evaluation, treatment, including supportive-care, and follow-up for patients with myeloma. These NCCN Guidelines Insights highlight the important updates/changes specific to the myeloma therapy options in the 2018 version of the NCCN Guidelines.

UR - http://www.scopus.com/inward/record.url?scp=85040224540&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2018.0002

DO - 10.6004/jnccn.2018.0002

M3 - Review article

C2 - 29295877

AN - SCOPUS:85040224540

SN - 1540-1405

VL - 16

SP - 11

EP - 20

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 1

ER -

Multiple Myeloma, version 3.2018: Featured updates to the NCCN guidelines

Abstract

Access to Document

Other files and links

Fingerprint

Cite this